- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Results
11
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
11 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DXCM | US$75.24 | 3.7% | -32.1% | US$29.2b | US$95.31 | PE43.2x | E16.8% | n/a | ||
BSX | US$90.17 | 1.6% | 62.7% | US$133.1b | US$97.00 | PE74.1x | E23.2% | n/a | ||
UNH | US$600.50 | -0.9% | 10.4% | US$531.0b | US$623.93 | PE38.6x | E24.6% | 1.4% | ||
BAX | US$32.63 | 0% | -9.0% | US$16.6b | US$40.52 | PE137.7x | E39.8% | 2.1% | ||
COO | US$99.08 | -2.7% | 16.9% | US$19.7b | US$114.29 | PE54.9x | E23.0% | 0% | ||
GMED | US$83.59 | 1.3% | 81.8% | US$11.3b | US$90.54 | PE124.4x | E48.3% | n/a | ||
CI | US$323.39 | -2.6% | 12.2% | US$89.7b | US$399.00 | PE29.6x | E24.4% | 1.7% | ||
SWAV | US$334.75 | 0.2% | 15.8% | US$12.6b | US$326.05 | PE76.9x | E18.4% | n/a | ||
BDX | US$222.39 | -3.8% | -6.1% | US$64.4b | US$280.88 | PE44.1x | E15.6% | 1.7% | ||
LH | US$237.85 | -3.4% | 12.4% | US$19.8b | US$261.25 | PE45.7x | E20.6% | 1.2% | ||
MOH | US$294.64 | -4.7% | -19.2% | US$16.2b | US$369.20 | PE14.7x | E14.8% | n/a |
Page 1 of 1